Who was I to question their proven wisdom? What I didn’t know: Valeant was no Berkshire Hathaway. Sequoia did well for four years after I first recommended it. From August 31, 2011, through ...

The FDA has finally approved Valeant’s eye drug Vyzulta after the company finally satisfied the regulator’s concerns over its manufacturing facility in Florida. The Quebec-based company’s ...

GSK will also gain the rights to Valeant's back-up compounds that target potassium channels. Valeant receives an upfront payment of $125 million, and will share up to 50% of net profits on ...

Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures, and markets a range of branded and generic pharmaceuticals, over-the ...

Bill Ackman, the billionaire founder of Pershing Square Capital, spent nearly four hours hosting a call defending his massive investment in Valeant Pharmaceuticals. Ackman has lost more than $1 ...

Bill Ackman, the billionaire hedge fund activist, has parachuted one of his representatives on to the board of Zoetis, the $22bn animal health company he is trying to shake up or sell. Zoetis, the ...